CTCs isolated from patients with ABI- or ENZ-resistant metastasis showed amplification in the FOXA1 gene in > 30% of CRPC patients, pinpointing the crucial role of FOXA1 in AR regulation and tumor progression[71]. The gene discussed is AR; the disease is neoplasm.